rethinkPeptides Search
Menu
Research citation

Cardiorenal safety and efficacy of angiotensin receptor-neprilysin inhibitors in heart failure across the ejection fraction spectrum: A meta-analysis and meta-regression of RCTs with 28,001 patients.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Cardiorenal safety and efficacy of angiotensin receptor-neprilysin inhibitors in heart failure across the ejection fraction spectrum: A meta-analysis and meta-regression of RCTs with 28,001 patients.

Biomedical reports, 24(2), 23

Citation

Rampengan, Derren D C H; Surya, Stevanus C; Tjandra, Kevin C; Lele, Juan A J M N; Rampengan, Starry H; Kadariswantiningsih, Ika N; Idrisov, Bulat; Idrisova, Alina; Empitu, Maulana A. (2026). Cardiorenal safety and efficacy of angiotensin receptor-neprilysin inhibitors in heart failure across the ejection fraction spectrum: A meta-analysis and meta-regression of RCTs with 28,001 patients.. Biomedical reports, 24(2), 23. https://doi.org/10.3892/br.2025.2096